Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Alzheimer

Mar 27, 2019

Alzheimer’s drug fails! Is it time to move on?

Feb 16, 2018

Symdeko’s approval; Erytech target solid tumors; Oncologie snapped bavituximab; Merck delivers

Sep 28, 2017

Alzeimer’s drug; Guardant Health receives approval; First Patient Dosed in Phase 1 Clinical Trial; Sunny Pharmtech and Vitruvias Therapeutics Receive FDA Approval

Newsletter/Whitepaper